Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Nakaraang pagsara
NT$159.00
Sakop ng araw
NT$160.50 - NT$168.00
Sakop ng taon
NT$54.10 - NT$277.00
Market cap
257.94B TWD
Average na Volume
5.86M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (TWD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.42M | -42.32% |
Gastos sa pagpapatakbo | 210.81M | 24.63% |
Net na kita | -7.73M | 94.38% |
Net profit margin | -57.62 | 90.26% |
Kita sa bawat share | -0.01 | 89.90% |
EBITDA | -195.81M | -32.61% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (TWD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.52B | -32.78% |
Kabuuang asset | 9.46B | -3.53% |
Kabuuang sagutin | 78.32M | 11.51% |
Kabuuang equity | 9.38B | — |
Natitirang share | 1.55B | — |
Presyo para makapag-book | 26.28 | — |
Return on assets | -5.31% | — |
Return on capital | -5.36% | — |
Cash Flow
Net change in cash
| (TWD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -7.73M | 94.38% |
Cash mula sa mga operasyon | -68.22M | 42.90% |
Cash mula sa pag-invest | -4.46B | -23,338.31% |
Cash mula sa financing | -21.40M | -100.33% |
Net change in cash | -4.57B | -171.70% |
Malayang cash flow | -196.01M | -70.93% |
Tungkol
Itinatag
2012
Website
